TY - JOUR T1 - Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset JF - BMJ Open Diabetes Research & Care JO - BMJ Open Diab Res Care DO - 10.1136/bmjdrc-2022-002849 VL - 10 IS - 3 SP - e002849 AU - Chris Worth AU - Yesica Tropeano AU - Pon Ramya Gokul AU - Karen E Cosgrove AU - Maria Salomon-Estebanez AU - Senthil Senniappan AU - Antonia Dastamani AU - Indraneel Banerjee Y1 - 2022/06/01 UR - http://drc.bmj.com/content/10/3/e002849.abstract N2 - Introduction Hypoglycemia is often recurrent and severe in patients with congenital hyperinsulinism (CHI). However, there is little information regarding frequency or patterns of episodes to inform clinical management and future trial design.Research design and methods We aimed to describe frequency and patterns of hypoglycemia by varying thresholds through a large continuous glucose monitoring (CGM) dataset. Through the UK CHI centers of excellence, data were analyzed from patients with CHI over a 5-year period. Hypoglycemia thresholds of 3.0 (H3.0), 3.5 (H3.5) and 3.9 (H3.9) mmol/L were used to test threshold change on hypoglycemia frequencies.Results From 63 patients, 3.4 million data points, representing 32 years of monitoring, were analyzed. By UK consensus threshold H3.5, patients experienced a mean 1.3 hypoglycemic episodes per day. Per cent time hypoglycemic increased from 1.2% to 3.3% to 6.9% when threshold changed from H3.0 to H3.5 and H3.9. Merged data showed periodicity of hypoglycemia risk in 24-hour periods in all patients.Conclusions We have evaluated a large dataset to provide a comprehensive picture of the frequency and patterns of hypoglycemia for patients with CHI in the UK. These data establish a baseline risk of hypoglycemia by CGM and provide a framework for clinical management and clinical trial design.Data are available upon reasonable request. Data were used as part of a service evaluation and thus are not freely available for research purposes. If data were required to be shared, this could be organized with the appropriate legalities and ethical approval. ER -